Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR Public Health and Surveillance

Date Submitted: Feb 20, 2026
Open Peer Review Period: Feb 20, 2026 - Apr 17, 2026
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Gender-Based Disparities in Mortality, Disability Adjusted Life Years and Risk Factors Burden in Pakistan: Insights from the Global Burden of Disease Study 2023

  • Uzma Rahim Khan; 
  • Ahmed Raheem; 
  • Zeeshan Ahsan; 
  • Aliza Shah; 
  • Aisha Abdul-Qadir; 
  • Syed Waqas; 
  • Ali Abidi; 
  • Shahzad Shamim

ABSTRACT

Background:

Gender disparities in disease burden remain a critical public health concern, particularly in low- and middle-income countries like Pakistan. Existing studies that have explored such inequities in Pakistan have categorized health outcomes only at the broad Level 1 classification, including communicable diseases, NCDs, and injuries, without gender specific data.

Objective:

This study aimed to compare gender-based differences in mortality and disability-adjusted life years for the causes and risk factors in Pakistan in 2023, using data from the Global Burden of Disease.

Methods:

We conducted an ecological study using the Global Burden of Disease dataset for Pakistan, aged ≥20 years. We ranked the gender-aggregated and gender-disaggregated top causes based on mortality and disability-adjusted life years in Pakistan in the year 2023. Additionally, we calculated the absolute difference in cause-specific mortality and DALY rates between females and males. We ranked the risk factors for gender-aggregated and gender-disaggregated data in Pakistan in the year 2023.

Results:

In 2023, ischemic heart disease (IHD) (136; 95% UI: 170.4–105.1) and stroke (80.8; 95% UI: 113.7–57.9) were the leading causes of mortality among adults aged 20 years and above, as well as among males and females in Pakistan. The leading causes of DALYs were also IHD (3727.6; 95% UI: 2877.3–4687.7) and stroke (2175.1; 95% UI: 1598.2–3004.7), among males and females. Males experienced higher DALY losses from tuberculosis (2090.8; 95% UI: 1326–2971.5), road injuries (1706.7; 95% UI: 977.6–2388.1), and self-harm (864.1; 95% UI: 527–1273.6), while females were more affected by low back pain (1554.7; 95% UI: 1079.8–2126.1), depressive disorders (1538.5; 95% UI: 1042.4–2197.4), and dietary iron deficiency (1043.7; 95% UI: 461.9–1863.5). The greatest absolute difference for mortality and DALYs among males was reported for tuberculosis, while for females, rheumatic heart disease was reported for mortality, and lower back pain for DALYs. The leading risk factors for both gender-aggregated and gender-disaggregated mortality were diets low in nuts and seeds and particulate matter pollution for DALYs.

Conclusions:

Our findings show IHD and stroke were the leading causes of mortality and DALYs among adults aged 20 years and above in Pakistan in 2023, reflecting the continued dominance of non-communicable diseases. This highlights the importance of gender-disaggregated analysis in national health reporting. Tailored interventions addressing these disparities are crucial for equitable healthcare planning in Pakistan.


 Citation

Please cite as:

Khan UR, Raheem A, Ahsan Z, Shah A, Abdul-Qadir A, Waqas S, Abidi A, Shamim S

Gender-Based Disparities in Mortality, Disability Adjusted Life Years and Risk Factors Burden in Pakistan: Insights from the Global Burden of Disease Study 2023

JMIR Preprints. 20/02/2026:93792

DOI: 10.2196/preprints.93792

URL: https://preprints.jmir.org/preprint/93792

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.